Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tag: Tmax (time to maximum concentration)

BA-BE Studies: SOP for Clinical Phase Audit Preparation – V 2.0

Posted on By

BA-BE Studies: SOP for Clinical Phase Audit Preparation – V 2.0 Standard Operating Procedure for Clinical Phase Audit Preparation in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/100/2025 Supersedes SOP/BA-BE/100/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the process for preparing the clinical…

Read More “BA-BE Studies: SOP for Clinical Phase Audit Preparation – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Interim Clinical Monitoring Reports – V 2.0

Posted on By

BA-BE Studies: SOP for Interim Clinical Monitoring Reports – V 2.0 Standard Operating Procedure for Interim Clinical Monitoring Reports in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/099/2025 Supersedes SOP/BA-BE/099/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define the procedure for preparing, reviewing, and…

Read More “BA-BE Studies: SOP for Interim Clinical Monitoring Reports – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Maintaining Blinding in Blinded Studies – V 2.0

Posted on By

BA-BE Studies: SOP for Maintaining Blinding in Blinded Studies – V 2.0 Standard Operating Procedure for Maintaining Blinding in Blinded Studies Department BA-BE Studies SOP No. SOP/BA-BE/098/2025 Supersedes SOP/BA-BE/098/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To outline the procedure for maintaining the integrity of…

Read More “BA-BE Studies: SOP for Maintaining Blinding in Blinded Studies – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Monitoring Compliance of Subject Activities – V 2.0

Posted on By

BA-BE Studies: SOP for Monitoring Compliance of Subject Activities – V 2.0 Standard Operating Procedure for Monitoring Compliance of Subject Activities in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/097/2025 Supersedes SOP/BA-BE/097/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To establish a uniform procedure for…

Read More “BA-BE Studies: SOP for Monitoring Compliance of Subject Activities – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Handling of Vomiting or Spitting Cases Post-Dose – V 2.0

Posted on By

BA-BE Studies: SOP for Handling of Vomiting or Spitting Cases Post-Dose – V 2.0 Standard Operating Procedure for Handling of Vomiting or Spitting Cases Post-Dose in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/096/2025 Supersedes SOP/BA-BE/096/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define…

Read More “BA-BE Studies: SOP for Handling of Vomiting or Spitting Cases Post-Dose – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Documenting Concomitant Medication Usage – V 2.0

Posted on By

BA-BE Studies: SOP for Documenting Concomitant Medication Usage – V 2.0 Standard Operating Procedure for Documenting Concomitant Medication Usage in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/095/2025 Supersedes SOP/BA-BE/095/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define a standardized procedure for documenting concomitant…

Read More “BA-BE Studies: SOP for Documenting Concomitant Medication Usage – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Transport of Plasma Samples to Bioanalytical Lab – V 2.0

Posted on By

BA-BE Studies: SOP for Transport of Plasma Samples to Bioanalytical Lab – V 2.0 Standard Operating Procedure for Transport of Plasma Samples to Bioanalytical Lab Department BA-BE Studies SOP No. SOP/BA-BE/094/2025 Supersedes SOP/BA-BE/094/2022 Page No. Page 1 of 9 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To define a standardized and…

Read More “BA-BE Studies: SOP for Transport of Plasma Samples to Bioanalytical Lab – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Post-Dosing Restrictions and Observations – V 2.0

Posted on By

BA-BE Studies: SOP for Post-Dosing Restrictions and Observations – V 2.0 Standard Operating Procedure for Post-Dosing Restrictions and Observations in BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/093/2025 Supersedes SOP/BA-BE/093/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To establish a uniform procedure for enforcing post-dosing…

Read More “BA-BE Studies: SOP for Post-Dosing Restrictions and Observations – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Emergency Medical Handling in BE Units – V 2.0

Posted on By

BA-BE Studies: SOP for Emergency Medical Handling in BE Units – V 2.0 Standard Operating Procedure for Emergency Medical Handling in BE Units Department BA-BE Studies SOP No. SOP/BA-BE/092/2025 Supersedes SOP/BA-BE/092/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose To outline a clear and systematic approach…

Read More “BA-BE Studies: SOP for Emergency Medical Handling in BE Units – V 2.0” »

BA-BE Studies V 2.0

BA-BE Studies: SOP for Data Entry and Source Documentation in Clinical Phase – V 2.0

Posted on By

BA-BE Studies: SOP for Data Entry and Source Documentation in Clinical Phase – V 2.0 Standard Operating Procedure for Data Entry and Source Documentation in Clinical Phase of BA/BE Studies Department BA-BE Studies SOP No. SOP/BA-BE/091/2025 Supersedes SOP/BA-BE/091/2022 Page No. Page 1 of 10 Issue Date 17/04/2025 Effective Date 20/04/2025 Review Date 17/04/2026 1. Purpose…

Read More “BA-BE Studies: SOP for Data Entry and Source Documentation in Clinical Phase – V 2.0” »

BA-BE Studies V 2.0

Posts pagination

Previous 1 2 3 … 16 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme